Skip to content

Clinical trials

Phase 1/2 Colorectal Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colorectal Neoplasms Phase: Phase 1/2 Country / region: Germany Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20061
20071
20082
20091
20101
20112
20121
20162
20175
20181
20191
20204
20212
20223
20231
20242
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting11
Active, not recruiting5
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioNTech SE2
Bristol-Myers Squibb2
Daiichi Sankyo2
Novartis Pharmaceuticals2
4SC AG1
AIO-Studien-gGmbH1
AmMax Bio, Inc.1
Boehringer Ingelheim1
Bold Therapeutics, Inc.1
Cantargia AB1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colorectal Neoplasms38
Carcinoma, Non-Small-Cell Lung8
Neoplasms6
Pancreatic Neoplasms6
Endometrial Neoplasms5
Lung Neoplasms5
Neoplasm Metastasis5
Stomach Neoplasms5
Breast Neoplasms4
Gastrointestinal Neoplasms4

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.